RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Valeo Pharma Stock

Valeo Pharma ROA 2024

Valeo Pharma ROA

-0.67

Ticker

VPH.TO

ISIN

CA91915B1085

WKN

A2PLB4

In 2024, Valeo Pharma's return on assets (ROA) was -0.67, a 52.72% increase from the -0.44 ROA in the previous year.

Valeo Pharma Aktienanalyse

What does Valeo Pharma do?

Valeo Pharma Inc is a pharmaceutical company that was founded in 2003. It is based in Montreal, Canada and its stocks are traded on the Toronto Stock Exchange. The company specializes in the development, manufacturing, and marketing of innovative pharmaceutical and medical products to help patients in Canada and around the world. Valeo Pharma's business model is based on identifying unmet medical needs, particularly in niche markets where there is a demand for innovative solutions. The company recognizes that there are difficulties for patients and healthcare professionals in finding specific medications suitable for their treatment needs in these niche markets. Valeo Pharma aims to fill this gap by developing innovative products tailored to the specific needs of patients and professionals, differentiating itself from other standard products. Valeo Pharma operates in two main business areas: Pharmaceuticals and OTC - Over-the-Counter. The pharmaceutical division of Valeo Pharma focuses on the development of drugs for the treatment of diseases that are currently inadequately treated. Their products in this area include drugs for the treatment of neurology, oncology, infectious diseases, dermatology, and psychiatry. Valeo Pharma's OTC division specializes in the development of products for self-medication and disease prevention. Their products in this area include pain relief products, cold and cough treatments, and general health support. Some of Valeo Pharma's key products include Blexten, an antihistamine for the treatment of seasonal and perennial allergic rhinitis as well as chronic idiopathic urticaria, and Redesca, a product for the prevention of blood clots and reducing the risk of thrombosis in patients with various medical conditions. Valeo Pharma has formed various partnerships with leading pharmaceutical companies around the world to bring its products to market. Through these partnerships, the company can expand its reach and offer exclusive products to its customers in different regions. Valeo Pharma is committed to research and development of new products that meet the needs of patients and healthcare professionals. The company invests in the development of active substances that treat diseases that are currently inadequately treated or have no effective medical treatments available. Overall, Valeo Pharma has established itself as a leading pharmaceutical company in Canada, focusing on providing innovative products to improve the health and well-being of patients. The company has a strong presence in the Canadian and international pharmaceutical industry and aims to expand its business through the development and marketing of innovative products and the formation of further strategic partnerships with pharmaceutical companies. Valeo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Valeo Pharma's Return on Assets (ROA)

Valeo Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Valeo Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Valeo Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Valeo Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Valeo Pharma stock

What is the Return on Assets (ROA) of Valeo Pharma this year?

The Return on Assets (ROA) of Valeo Pharma is -0.67 undefined this year.

What was the ROA of Valeo Pharma compared to the previous year?

The ROA of Valeo Pharma has increased by 52.72% compared to the previous year.

What consequences do high ROA have for investors of Valeo Pharma?

A high ROA is advantageous for investors of Valeo Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Valeo Pharma?

A low ROA can be unfavorable for investors of Valeo Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Valeo Pharma affect the company?

An increase in ROA of Valeo Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Valeo Pharma impact the company?

A reduction in the ROA of Valeo Pharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Valeo Pharma?

Some factors that can influence the ROA of Valeo Pharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Valeo Pharma important for investors?

The ROA of Valeo Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Valeo Pharma take to improve ROA?

To improve ROA, Valeo Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Valeo Pharma pay?

Over the past 12 months, Valeo Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Valeo Pharma is expected to pay a dividend of 0 CAD.

What is the dividend yield of Valeo Pharma?

The current dividend yield of Valeo Pharma is .

When does Valeo Pharma pay dividends?

Valeo Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Valeo Pharma?

Valeo Pharma paid dividends every year for the past 0 years.

What is the dividend of Valeo Pharma?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Valeo Pharma located?

Valeo Pharma is assigned to the '-' sector.

Wann musste ich die Aktien von Valeo Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Valeo Pharma from 11/5/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did Valeo Pharma pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of Valeo Pharma in the year 2023?

In the year 2023, Valeo Pharma distributed 0 CAD as dividends.

In which currency does Valeo Pharma pay out the dividend?

The dividends of Valeo Pharma are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Valeo Pharma

Our stock analysis for Valeo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Valeo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.